0001127602-24-011901.txt : 20240402 0001127602-24-011901.hdr.sgml : 20240402 20240402170133 ACCESSION NUMBER: 0001127602-24-011901 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Stan CENTRAL INDEX KEY: 0001913199 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 24815360 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-31 0001878313 MAIA Biotechnology, Inc. MAIA 0001913199 Smith Stan 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Stock Options 2.20 2024-03-31 4 A 0 11491 0 A 2024-03-31 2034-03-31 Common Stock 11491 11491 I See Footnote The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnlogy, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. These securities are beneficailly owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. /s/ Stan V. Smith 2024-04-02